Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
83%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(1)
Terminated(2)
Other(3)

Detailed Status

unknown3
Withdrawn2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (16.7%)
N/A5 (83.3%)

Trials by Status

unknown350%
completed117%
withdrawn233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6